Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05062980 |
| Title | Reqorsa (Quaratusugene Ozeplasmid) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer (Acclaim-2) |
| Acronym | Acclaim-2 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Genprex, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center - Magnolia Campus | Tampa | Florida | 33612 | United States | Details | |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | United States | Details | |
| Washington University School of Medicine - Siteman Cancer Center | St. Louis | Missouri | 63110 | United States | Details | |
| The Valley Hospital - Luckow Pavilion | Paramus | New Jersey | 07652 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details | |
| Millennium Oncology | Houston | Texas | 77090 | United States | Details |